• Keine Ergebnisse gefunden

Swiss Guidelines 2011 for Drugs of Abuse Testing Swiss Guidelines Committee for Drugs of Abuse testing (SCDAT): Rudolf Brenneisen

N/A
N/A
Protected

Academic year: 2022

Aktie "Swiss Guidelines 2011 for Drugs of Abuse Testing Swiss Guidelines Committee for Drugs of Abuse testing (SCDAT): Rudolf Brenneisen"

Copied!
1
0
0

Wird geladen.... (Jetzt Volltext ansehen)

Volltext

(1)

Swiss Guidelines 2011 for Drugs of Abuse Testing

Swiss Guidelines Committee for Drugs of Abuse testing (SCDAT):

Rudolf Brenneisen1, Ingeborg Bertschi2, Thomas Briellmann3, Katharina Rentsch4, André Deom5, Hans Küffer6, André Scholer7, Pierre-Alain Binz8,9

1 Department of Clinical Research, University of Bern, Bern, Switzerland

2 Abbott AG, Baar, Switzerland

3 Institute of legal medicine, Basel, Switzerland

4 Institute of Clinical Chemistry, University Hospital, Zurich, Switzerland

5 Veyrier, Switzerland

6 Grimisuat, Switzerland

7 Bottmingen, Switzerland

8 Swiss Institute of Bioinformatics, Geneva, Switzerland

9 Geneva Bioinformatics SA, Geneva Switzerland

Key words: drugs of abuse testing, guidelines

The Drugs of Abuse Testing (DAT) Laboratory Guidelines are a revision of the Swiss AGSA guidelines published in 1996 and are permanently revised by a committee representing members of institutions such as the Swiss Federal Office of Public Health, the Swiss Association of Pharmacists, the Swiss Society for Clinical Chemistry, the Swiss Society of Legal Medicine, the Swiss Association of Diagnostics Manufacturers, the Swiss Society for Directors of Clinical Laboratories and the University of Bern. The committee (SCDAT) works under the auspices of the Swiss Union for Laboratory Medicine.

The guidelines contain a valuation of today’s applied methods in drug analysis (onsite tests, instrumental immunoassays, chromatography, mass spectrometry) in urine and blood, recommendations for cut-off values, comments on quality assurance, documentation, interpretation and legal aspects in the therapeutical (medical), forensic and social field as well as in workplace DAT. Short reviews of pharmacokinetics of some important drugs of abuse complete the document.

The DAT guidelines are intended as recommendations and have no legally binding intention.

The objectives of SCDAT are to periodically update and harmonize DAT in Switzerland in accordance with international guidelines.

The 2011 DAT guidelines are published in German, English and French and will be accessible via www.scdat.ch.

Toxichem Krimtech 2011;78(Special Issue):391

Referenzen

ÄHNLICHE DOKUMENTE

TRANSPOREON Time Slot Management is a web-based logistics platform which your forwarding agent can use to book a time slot for delivering goods to CVK on the Internet.. This

The strategy for control and prevention of IDA would be provision of IFA supplementation and therapeutic management of mild, moderate and severe anaemia in the most

Therefore, with the increase of student drug pushers in the school compound, the accessibility of drugs among the young generations is further increased..

If the reference standard being used to determine test accuracy is imperfect, and it is therefore unclear whether the false positives or false negatives ascertained using

In many sqnrficant ways the mountains of the world have made major contributions to the growth of human civrkzations. Though not adequately recognized, these roles are

The Maltreatment and Abuse Chronology of Exposure (MACE) scale was de- veloped in a sample of 1051 participants using item response theory to gauge severity of exposure to ten types

Matthias Egger is head of the Department of Social and Preventive Medicine, University of Berne, Switzerland and also a visiting professor of clinical epidemiology at University

A Standard Computable General Equilibrium Model in GAMS, Microcomputers in Policy Research, No.5, International Food Policy Research Institute (IFPRI).